On September 2, Argan declined 5.05% in regular trading, trading at $403.89/share, with turnover of approximately $109 million. The stock retreated sharply from the prior session's close of $424.99 as investors positioned cautiously ahead of a key earnings release.

The company is scheduled to report its fiscal second-quarter results after market close today. Market consensus expects quarterly revenue of approximately $301 million, representing a 26.45% year-over-year increase, with adjusted earnings per share estimated at $2.64, up 61.10% year-over-year. While expectations remain robust, heightened stock price volatility in recent sessions has amplified market concerns over whether the company can sustain its strong growth trajectory.

For context, Argan delivered a significant earnings beat in its prior fiscal Q4 report, posting EPS of $3.47 versus the $1.96 consensus estimate, a 77% surprise. Last quarter, revenue reached $291 million with a net margin of 15.83% and adjusted EPS of $3.24, up 102.50% year-over-year. The high bar set by recent outperformance appears to be contributing to pre-earnings anxiety among market participants.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)